Acne LesionsAcneDectNCT04060160
Acne Detection Software (AcneDect)
An observational study of Acne Lesions and Acne Vulgaris, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
Trial summary
This study is to create a self-learning software that can detect acne lesions. Patients take a picture of their face every single day for 3 months with a secure mobile phone and fill out a pre-designed questionnaire. Read more about this study
- Who is it for?
- Ages 10 to 35 years
- Conditions the study is for
- Acne Lesions, Acne Vulgaris
- What is being tested?
- Self- learning software that can detect acne lesions and Patient reported outcomes
- How many people
- 25 participants
- Where
- 1 siteSwitzerland
- Study dates
- 29 Oct 2020to 30 Sep 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 35 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Patients within the consultation service of Dermatologische Klinik, Universitätsspital Basel, that meet the inclusion criteria
Who may be able to join
- Acne vulgaris
Who cannot join
- Refusal to participate
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Department of Dermatology, University Hospital Basel
Basel, 4031
About this study
Official title: Acne Detection Software (AcneDect); AcneDect: a Software to Detect Acne Lesions
This study is to create a self-learning software that can detect acne lesions. Patients take a picture of their face every single day for 3 months with a secure mobile phone and fill out a pre-designed questionnaire. After 3 months, the mobile will be collected back and the pictures will be evaluated by 3 dermatologists. The software is able to learn from the dermatologists' evaluation and -using machine learning- a mechanism that should be able to automatically detect acne to some extent will be established.
- Conditions
- Acne Lesions, Acne Vulgaris
- Being tested
- Self- learning software that can detect acne lesions, Patient reported outcomes
- Keywords
- machine learning, self-learning software, image-detecting software
- Medical subject headings
- Acne Vulgaris
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Self- learning software that can detect acne lesionsOther
Self- learning software that can detect acne lesions from patients who take a picture of their face every single day for 3 months with a secure mobile phone.
Patient reported outcomesOther
Collection of patient reported outcomes and clinical data via a mobile electronic case report form
What is being measured
The primary outcome is the main question the study is designed to answer.
Pictures to train the AcneDect software
Collection of pictures to train the AcneDect software to detect change in acne lesions
Measured: every single day from baseline for 3 months
Secondary outcomes (1)
AcneDect questionnaire regarding acne burden (Visual Analogue Scale (VAS) scale ranging from "Not bad at all" to "Very bad")
Collection of patient reported outcomes via a mobile electronic case report form
Measured: every single day from baseline for 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Aug 2019
- Study start29 Oct 2020
- Primary completion30 Sep 2024
- Study completion30 Sep 2024
Why it stopped: After careful consideration and review of the data, the study team has determined that it is in the best interest of all parties involved to conclude the study at this juncture.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acne LesionsStudies of the same condition, open and under way.
- More trials run by University Hospital, Basel, SwitzerlandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 25 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Alexander A. Navarini, Prof. Dr. MD, Principal investigator, Dermatologische Klinik; Universitätshospital Basel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04060160
- Sponsor's protocol ID
- 2018-00702; sp19Navarini
- Other IDs
- 2018
- Acronym
- AcneDect
- Status last verified
- Jan 2025
- First submitted
- 15 Aug 2019
- Last updated
- 15 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Acne Detection Software (AcneDect); AcneDect: a Software to Detect Acne Lesions
- ClinicalTrials.gov ID
- NCT04060160
- Acronym / sponsor ID
- AcneDect / 2018-00702; sp19Navarini
- Conditions
- Acne Lesions, Acne Vulgaris
- Keywords
- machine learning, self-learning software, image-detecting software
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: After careful consideration and review of the data, the study team has determined that it is in the best interest of all parties involved to conclude the study at this juncture.
- Enrolment
- 25 participants (actual)
- Lead sponsor
- University Hospital, Basel, SwitzerlandUniversity, hospital or other
- Study start
- 29 Oct 2020 (actual)
- Primary completion
- 30 Sep 2024 (actual)
- Study completion
- 30 Sep 2024 (actual)
- First posted
- 16 Aug 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is to create a self-learning software that can detect acne lesions. Patients take a picture of their face every single day for 3 months with a secure mobile phone and fill out a pre-designed questionnaire. After 3 months, the mobile will be collected back and the pictures will be evaluated by 3 dermatologists. The software is able to learn from the dermatologists' evaluation and -using machine learning- a mechanism that should be able to automatically detect acne to some extent will be established.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 10 to 35 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Patients within the consultation service of Dermatologische Klinik, Universitätsspital Basel, that meet the inclusion criteria
Key inclusion criteria (1 listed)
- Acne vulgaris
Key exclusion criteria (1 listed)
- Refusal to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Self- learning software that can detect acne lesionsSelf- learning software that can detect acne lesions from patients who take a picture of their face every single day for 3 months with a secure mobile phone. | Other | – |
| Patient reported outcomesCollection of patient reported outcomes and clinical data via a mobile electronic case report form | Other | – |
Primary outcome
Pictures to train the AcneDect software
Time frame: every single day from baseline for 3 months
Collection of pictures to train the AcneDect software to detect change in acne lesions
1 secondary outcome
AcneDect questionnaire regarding acne burden (Visual Analogue Scale (VAS) scale ranging from "Not bad at all" to "Very bad")
Time frame: every single day from baseline for 3 months
Results and safety
The study was stopped early (reason given: After careful consideration and review of the data, the study team has determined that it is in the best interest of all parties involved to conclude the study at this juncture.). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jan 2025.
Related trials for Acne Lesions
Active, not recruiting
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
Hair Reduction, Tattoo Removal
Not yet recruitingPhase 2
Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
Hidradenitis Suppurativa
Recruiting
AVAVA MIRIA General Use
Acne, Acne Scars - Mixed Atrophic and Hypertrophic
Not yet recruiting
Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation
Acne Vulgaris
Active, not recruitingPhase 2/3
Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome
Acne Vulgaris
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alexander A. Navarini, Prof. Dr. MD principal investigator
Dermatologische Klinik; Universitätshospital Basel
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acne Lesions and Acne Vulgaris, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 15 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: After careful consideration and review of the data, the study team has determined that it is in the best interest of all parties involved to conclude the study at this juncture.). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pictures to train the AcneDect software (time frame: every single day from baseline for 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2025.